These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1692254)

  • 1. Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cells.
    Skalski V; Feindel W; Panasci LC
    Cancer Res; 1990 May; 50(10):3062-6. PubMed ID: 1692254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
    Noë AJ; Malapetsa A; Panasci LC
    Mol Pharmacol; 1993 Jul; 44(1):204-9. PubMed ID: 8341272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
    Skalski V; Yarosh DB; Batist G; Gros P; Feindel W; Kopriva D; Panasci LC
    Mol Pharmacol; 1990 Sep; 38(3):299-305. PubMed ID: 2402223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.
    Noë AJ; Malapetsa A; Panasci LC
    Cancer Res; 1994 Mar; 54(6):1491-6. PubMed ID: 8137253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Skalski V; Feindel W; Panasci LC
    J Neurooncol; 1989 Jul; 7(2):189-93. PubMed ID: 2476532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.
    Malapetsa A; Bramson JL; Noë AJ; Panasci LC
    Cancer Chemother Pharmacol; 1992; 31(2):146-50. PubMed ID: 1280536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity.
    Noë AJ; Marcantonio D; Barton J; Malapetsa A; Panasci LC
    Biochem Pharmacol; 1996 Jun; 51(12):1639-48. PubMed ID: 8687479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity.
    Panasci LC; Marcantonio D; Noë AJ
    Cancer Chemother Pharmacol; 1996; 37(6):505-8. PubMed ID: 8612302
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro.
    Goldenberg GJ; Lee M; Lam HY; Begleiter A
    Cancer Res; 1977 Mar; 37(3):755-60. PubMed ID: 837375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide- 1-nitrosourea in human tumor xenografts.
    Chen ZP; Wang ZM; Carter CA; Alley MC; Mohr G; Panasci LC
    J Pharmacol Exp Ther; 2001 Mar; 296(3):712-5. PubMed ID: 11181897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of L-thyroxine transport into hepatocytes isolated from juvenile rainbow trout (Oncorhynchus mykiss).
    Riley WW; Eales JG
    Gen Comp Endocrinol; 1993 Apr; 90(1):31-42. PubMed ID: 8504920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes.
    Segel GB; Simon W; Lichtman MA
    J Cell Physiol; 1983 Sep; 116(3):372-8. PubMed ID: 6604062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
    Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of L-arginine in cultured glial cells.
    Schmidlin A; Wiesinger H
    Glia; 1994 Jul; 11(3):262-8. PubMed ID: 7960030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man.
    Skalski V; Rivas J; Panasci L; McQuillan A; Feindel W
    Cancer Chemother Pharmacol; 1988; 22(2):137-40. PubMed ID: 3409444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
    Huynh H; Nguyen TH; Panasci L; Do P
    Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
    Chen ZP; Remack J; Brent TP; Mohr G; Panasci LC
    Clin Cancer Res; 1999 Dec; 5(12):4186-90. PubMed ID: 10632359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.